Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas
- PMID: 11355941
- PMCID: PMC2363635
- DOI: 10.1054/bjoc.2001.1790
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas
Abstract
Matrix metalloproteinases play a crucial role in tumour invasion and metastasis. Matrilysin (MMP-7) has been shown to correlate with nodal or distant metastasis in colorectal carcinomas; however, its implication in early invasive colorectal carcinomas has not been determined. This study was undertaken to clarify the association of matrilysin expression with clinicopathologic parameters in early invasive colorectal carcinomas. 38 early invasive colorectal carcinomas treated by local excision or radical surgery were examined. Tumour budding was evaluated as the number of dedifferentiation units along the entire invasive margin. Matrilysin protein levels were determined using immunohistochemical study. Univariate analysis showed that matrilysin expression alone was significantly associated with distant metastasis (P = 0.0339), and both tumour budding and matrilysin expression were significantly associated with adverse outcome (P = 0.0005, 0.0341). Histological differentiation, vessel invasion, and depth of invasion were not significantly associated with either distant metastasis or adverse outcome. Multivariate analysis confirmed that tumour budding and matrilysin expression were independently associated with adverse outcome, although the significance of matrilysin expression was marginal (P = 0.0488). Tumour budding at the invasive margin and matrilysin expression are more useful in identifying high-risk groups for adverse outcome in patients with early invasive colorectal carcinomas.
Copyright 2001 Cancer Research Campaign.
Similar articles
-
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.J Pathol. 2003 Aug;200(5):568-76. doi: 10.1002/path.1387. J Pathol. 2003. PMID: 12898592
-
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.J Pathol. 2003 Feb;199(2):176-84. doi: 10.1002/path.1277. J Pathol. 2003. PMID: 12533830
-
Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.J Gastroenterol. 2003;38(1):37-44. doi: 10.1007/s005350300004. J Gastroenterol. 2003. PMID: 12560920
-
[Prognostic significance of the molecular markers in human gastrointestinal cancer].Rinsho Byori. 2003 Feb;51(2):158-67. Rinsho Byori. 2003. PMID: 12690634 Review. Japanese.
-
[Genetic diagnosis of colorectal cancer].Hokkaido Igaku Zasshi. 1996 Jan;71(1):9-14. Hokkaido Igaku Zasshi. 1996. PMID: 8727369 Review. Japanese.
Cited by
-
Clinicopathological and biological significance of cripto overexpression in human colon cancer.World J Gastroenterol. 2013 Dec 14;19(46):8630-7. doi: 10.3748/wjg.v19.i46.8630. World J Gastroenterol. 2013. PMID: 24379580 Free PMC article.
-
Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration.Oncol Lett. 2011 May;2(3):483-488. doi: 10.3892/ol.2011.276. Epub 2011 Mar 21. Oncol Lett. 2011. PMID: 22866107 Free PMC article.
-
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.Oncotarget. 2015 May 30;6(15):13402-15. doi: 10.18632/oncotarget.2830. Oncotarget. 2015. PMID: 25596746 Free PMC article.
-
Inferring proteolytic processes from mass spectrometry time series data using degradation graphs.PLoS One. 2012;7(7):e40656. doi: 10.1371/journal.pone.0040656. Epub 2012 Jul 17. PLoS One. 2012. PMID: 22815782 Free PMC article.
-
MMP-7 as a prognostic marker in colorectal cancer.Tumour Biol. 2011 Apr;32(2):259-64. doi: 10.1007/s13277-010-0080-2. Epub 2010 Aug 28. Tumour Biol. 2011. PMID: 21207220
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical